A potent agonist of 5-HT1E and 5-HT1F
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BRL 54443

Item No. 21263

Technical Information
Formal Name
3-(1-methyl-4-piperidinyl)-1H-indol-5-ol
CAS Number
57477-39-1
Molecular Formula
C14H18N2O
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 12.5 mg/mLDMSO: 30 mg/mLDMSO:PBS(pH 7.2) (1:4): 0.2 mg/mLEthanol: 1.4 mg/mL
λmax
278 nm
SMILES
OC1=CC=C2C(C(C3CCN(C)CC3)=CN2)=C1
InChi Code
InChI=1S/C14H18N2O/c1-16-6-4-10(5-7-16)13-9-15-14-3-2-11(17)8-12(13)14/h2-3,8-10,15,17H,4-7H2,1H3
InChi Key
WKNFADCGOAHBPG-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    BRL 54443 is a potent agonist of the serotonin (5-HT) receptor subtypes 5-HT1E and 5-HT1F (Ki values are 1.1 and 0.7 nM, respectively).1 It displays more than 30-fold selectivity over other 5-HT and dopamine receptors. At higher concentrations, BRL 54443 induces 5-HT2A-mediated contraction of mouse thoracic aorta strips in vitro (pEC50 = 6.5).2 It significantly reduces formalin-induced pain in rat hind paw.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Klein, M.T., Dukat, M., Glennon, R.A., et alToward selective drug development for the human 5-hydroxytryptamine 1E receptor: A comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships. J. Pharmacol. Exp. Ther. 337(3), 860-867 (2011).

    2. McKune, C.M., and Watts, S.W. Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling. J. Pharmacol. Exp. Ther. 297(1), 88-95 (2001).

    3. Granados-Soto, V., Argüelles, C.F., Rocha-González, H.I., et alThe role of peripheral 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E and 5-HT1F serotonergic receptors in the reduction of nociception in rats. Neuroscience 165(2), 561-568 (2010).